Bayer advances into a new era of medicine

In the framework of its Pharma Media Day, Bayer presented advances in its growth strategy. Overall, this year the company will offer new therapies with the extension of its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy; a new alternative for patients with heart failure and a left ventricular ejection fraction equal to or greater than 40 percent; the innovative hormone-free therapeutic option to relieve modera…

Read a quick summary generated by AI × Summary of the news: In the last edition of INFARMA, Bayer organized a session entitled “Management of bacterial vaginosis in the pharmacy”, aimed at improving the knowledge of healthcare professionals about this condition. The session was attended by experts such as Dr. Evaristo Suárez Fernández and Dr. Ana Rosa Jurado, who offered valuable guidelines on diagnosis and treatment. Bacterial vaginosis is the …